Rigel Pharmaceuticals, Inc. earnings per share and revenue

RIGL earnings per share for the last quarter are 0.00 USD whereas the estimation was -0.02 USD which accounts for 100.00% surprise. Company revenue for the same period amounts to 35.79 M USD despite the estimated figure of 34.10 M USD. Estimated earnings per share for the next quarter are -0.03 USD, and revenue is expected to reach 31.47 M USD. Also watch annual changes over time to get a bigger picture of RIGL earnings per share and revenue dynamics.